{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:38:21Z","timestamp":1770824301613,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00428-012-1354-4","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T07:29:14Z","timestamp":1355815754000},"page":"27-37","source":"Crossref","is-referenced-by-count":65,"title":["Guideline on the requirements of external quality assessment programs in molecular pathology"],"prefix":"10.1007","volume":"462","author":[{"given":"J. Han","family":"van Krieken","sequence":"first","affiliation":[]},{"given":"Nicola","family":"Normanno","sequence":"additional","affiliation":[]},{"given":"Fiona","family":"Blackhall","sequence":"additional","affiliation":[]},{"given":"Elke","family":"Boone","sequence":"additional","affiliation":[]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[]},{"given":"Fatima","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Ilhan","family":"Celik","sequence":"additional","affiliation":[]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[]},{"given":"Ian A.","family":"Cree","sequence":"additional","affiliation":[]},{"given":"Zandra C.","family":"Deans","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Edsj\u00f6","sequence":"additional","affiliation":[]},{"given":"Patricia J. T. A.","family":"Groenen","sequence":"additional","affiliation":[]},{"given":"Outi","family":"Kamarainen","sequence":"additional","affiliation":[]},{"given":"Hans H.","family":"Kreipe","sequence":"additional","affiliation":[]},{"given":"Marjolijn J. L.","family":"Ligtenberg","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Marchetti","sequence":"additional","affiliation":[]},{"given":"Samuel","family":"Murray","sequence":"additional","affiliation":[]},{"given":"Frank J. M.","family":"Opdam","sequence":"additional","affiliation":[]},{"given":"Scott D.","family":"Patterson","sequence":"additional","affiliation":[]},{"given":"Simon","family":"Patton","sequence":"additional","affiliation":[]},{"given":"Carmine","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[]},{"given":"Ed","family":"Schuuring","sequence":"additional","affiliation":[]},{"given":"Silke","family":"Sterck","sequence":"additional","affiliation":[]},{"given":"Miquel","family":"Taron","sequence":"additional","affiliation":[]},{"given":"Sabine","family":"Tejpar","sequence":"additional","affiliation":[]},{"given":"Wim","family":"Timens","sequence":"additional","affiliation":[]},{"given":"Erik","family":"Thunnissen","sequence":"additional","affiliation":[]},{"given":"Peter M.","family":"van de Ven","sequence":"additional","affiliation":[]},{"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Dequeker","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"1354_CR1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2012.01.014","volume":"148","author":"JE Dancey","year":"2012","unstructured":"Dancey JE, Bedard PL, Onetto N, Hudson TJ (2012) The genetic basis for cancer treatment decisions. Cell 148:409\u2013420","journal-title":"Cell"},{"key":"1354_CR2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","volume":"10","author":"W Pao","year":"2010","unstructured":"Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760\u2013774","journal-title":"Nat Rev Cancer"},{"key":"1354_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00428-010-1000-y","volume":"458","author":"R Penzel","year":"2011","unstructured":"Penzel R et al (2011) EGFR mutation detection in NSCLC\u2014assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch 458:95\u201398","journal-title":"Virchows Arch"},{"key":"1354_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00428-011-1094-x","volume":"459","author":"E Dequeker","year":"2011","unstructured":"Dequeker E, Ligtenberg MJL, Vander Borght S, Van Krieken JJM (2011) Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme. Virchows Arch 459:155\u2013160","journal-title":"Virchows Arch"},{"key":"1354_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1634\/theoncologist.2010-0429","volume":"16","author":"E Bellon","year":"2011","unstructured":"Bellon E et al (2011) External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds. Oncologist 16:467\u2013478","journal-title":"Oncologist"},{"key":"1354_CR6","doi-asserted-by":"crossref","unstructured":"Wong NACS, Deans ZC, Ramsden SC (2012) The UK NEQAS for molecular genetics scheme for gastrointestinal stromal tumour: findings and recommendations following four rounds of circulation. J ClinPathol. doi: 10.1136\/jclinpath-2012-200851","DOI":"10.1136\/jclinpath-2012-200851"},{"key":"1354_CR7","unstructured":"International Organization for Standardization. ISO 17043:2010 Conformity assessment\u2014general requirements for proficiency testing. http:\/\/www.iso.org\/iso\/catalogue_detail.htm?csnumber=29366. Accessed 28 sept 2012"},{"key":"1354_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jcp.2003.011973","volume":"57","author":"FB Thunnissen","year":"2004","unstructured":"Thunnissen FB et al (2004) Dutch Pathology Molecular Diagnostic Working Group. Quality control in diagnostic molecular pathology in the Netherlands; proficiency testing for patient identification in tissue samples. J Clin Pathol 57:717\u2013720","journal-title":"J Clin Pathol"},{"key":"1354_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000121885","volume":"3","author":"R Wasielewski von","year":"2008","unstructured":"von Wasielewski R, Krusche CA, R\u00fcschoff J, Fisseler-Eckhoff A, Kreipe H (2008) Implementation of external quality assurance trials for immunohistochemically determined breast cancer biomarkers in Germany. Breast Care 3:128\u2013133","journal-title":"Breast Care"},{"key":"1354_CR10","unstructured":"International Organization for Standardization. ISO 15189:2003 Medical laboratories\u2014particular requirements for quality and competence. http:\/\/www.iso.org\/iso\/catalogue_detail?csnumber=42641. Accessed 28 Sept 2012"},{"key":"1354_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00000478-200207000-00005","volume":"26","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Hofler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach FE, Fischer HP, Mengel M, von Wasielewski R, Muller-Hermelink HK (2002) Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol 26:873\u2013882","journal-title":"Am J Surg Pathol"},{"key":"1354_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/path.1218","volume":"198","author":"M Mengel","year":"2002","unstructured":"Mengel M, von Wasielewski R, Wiese B, R\u00fcdiger T, M\u00fcller-Hermelink HK, Kreipe H (2002) Interlaboratory and interobserver reproducibility of immunohistochemical assessment of the Ki67-labelling index in a large multi-centre trial. J Pathol 198:292\u2013299","journal-title":"J Pathol"},{"key":"1354_CR13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/jclinpath-2011-200163","volume":"64","author":"E Thunnissen","year":"2011","unstructured":"Thunnissen E, Bov\u00e9e JV, Bruinsma H, van den Brule AJ, Dinjens W, Heideman DA, Meulemans E, Nederlof P, van Noesel C, Prinsen CR, Scheidel K, van de Ven PM, de Weger R, Schuuring E, Ligtenberg M (2011) EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy. J Clin Pathol 64:884\u2013892","journal-title":"J Clin Pathol"},{"key":"1354_CR14","volume-title":"Bayesian data analysis","author":"G Andrew","year":"2003","unstructured":"Andrew G, Carlin JB, Stern HS, Rubin DB (2003) Bayesian data analysis. Chapman & Hall, Boca Raton"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1354-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-012-1354-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1354-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:36:07Z","timestamp":1559079367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-012-1354-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s00428-012-1354-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}